Efficacy of Tixagevimab/Cilgavimab Prophylaxis and Vaccination on Omicron Variants (BA.1, BA.2, BA.5, and BQ.1.1) in Kidney Transplant Recipients

Clin J Am Soc Nephrol. 2023 Oct 1;18(10):1343-1345. doi: 10.2215/CJN.0000000000000241. Epub 2023 Jun 29.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibodies, Monoclonal
  • Humans
  • Kidney Transplantation* / adverse effects
  • Transplant Recipients
  • Vaccination

Substances

  • tixagevimab
  • cilgavimab
  • Antibodies, Monoclonal